Form 4 · Filed May 20, 2026, 11:29 PM UTC
IRD/Opus Genetics, Inc.
Foundation Fighting Blindness Retinal Degeneration Fund — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
1 row| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 18, 2026 | S | sell | 1,700,000 | $4 | $7,395,000 | 3,792,171 |
Source: SEC EDGAR raw filing ↗ · Accession 0002042266-26-000001